-
公开(公告)号:US11634473B2
公开(公告)日:2023-04-25
申请号:US16814088
申请日:2020-03-10
发明人: Erez Ilan , Kfir Regev , Dana Leitman , Israel Nur , Moti Meron , John Goodman
IPC分类号: C07K14/75 , A61M5/19 , A61M5/28 , B01F23/50 , B01F25/451 , B01F33/25 , B01F33/501 , B01F35/71
摘要: Provided are methods and devices for dissolving solid protein compositions, such as solid compositions comprising fibrinogen, in an aqueous solvent. The methods comprise use of a closed container containing a volume of solid fibrinogen composition and a head space wherein the pressure within the headspace is sub-atmospheric. Aqueous solvent is introduced into the container while maintain the sub-atmospheric pressure, and subsequent to addition of the solvent, the size of the headspace is decreased to bring the pressure to atmospheric pressure. The devices are suitable for use in the disclosed method.
-
公开(公告)号:US11578116B2
公开(公告)日:2023-02-14
申请号:US17377550
申请日:2021-07-16
IPC分类号: C07K14/705 , A61K47/69 , A61K47/58 , A61K47/62 , A61K47/54 , A61P27/02 , A61P37/06 , C12N9/14 , C07K14/75 , A61K38/00
摘要: Described herein are compositions and techniques related to generation and therapeutic application of artificial synapses. Artificial synapses are engineered extracellular vesicles, including exosomes, which incorporate sticky binders on their surface to anchor signaling domains against biological targets, such as receptors. These engineered additives can be organized in genetic vector constructs, expressed in mammalian cells, wherein the sticky binders attach to extracellular vesicles such as exosomes, thereby presenting their joined signaling domains which are rapidly taken up by recipient cells. Artificial synapses adopt the hallmark biophysical and biochemical features of extracellular vesicles, allowing for rapid deployment and scale-up. Importantly, this strategy can allow for kinetically favorable signal generation and signal propagation. This includes, for example, increasing density of agonist presentation to support receptor clustering—an onerous barrier for traditional receptor targeting strategies.
-
公开(公告)号:US20220372437A1
公开(公告)日:2022-11-24
申请号:US17765637
申请日:2020-09-09
申请人: OSAKA UNIVERSITY
发明人: Takaaki SAMURA , Shigeru MIYAGAWA , Yoshiki SAWA , Junya YOKOYAMA
摘要: A method for producing a fibrin sheet containing at least one selected from the group consisting of cells and drugs in a fibrin gel, the method comprising: a step 1 of applying a fibrinogen solution containing at least one selected from the group consisting of cells and drugs and fibrinogen dropwise onto a surface of a substrate made of a gelatin hydrogel; a step 2 of adding thrombin to the fibrinogen solution on the surface of the substrate; a step 3 of placing a support film on and in contact with a top surface of the fibrinogen solution to which the thrombin has been added; a step 4 of forming a fibrin sheet containing the at least one selected from the group consisting of cells and drugs in a fibrin gel between the substrate and the support film by a reaction between the fibrinogen and the thrombin; and a step 5 of melting the substrate at a temperature not lower than a melting temperature of the gelatin hydrogel to separate, from the substrate, the fibrin sheet supported by the support film.
-
公开(公告)号:US11071805B2
公开(公告)日:2021-07-27
申请号:US16041903
申请日:2018-07-23
发明人: Orgad Laub , Daniel Cohn , Eran Cohen , Matthew Zarek
IPC分类号: A61L15/16 , A61L15/32 , C07K14/75 , A61L27/22 , A61L27/60 , A61L27/36 , A61L27/58 , C09J175/04 , A61L27/18 , A61F2/10
摘要: A novel fibrinogen-based tissue adhesive patch is disclosed. The patch comprises a backing made from a non-permeable biocompatible polymer film into which a fibrinogen-based sealant is incorporated. In preferred embodiments of the invention, the biocompatible polymer film comprises units of a biocompatible block copolymer such as a polyethylene glycol-polycaprolactone-DL-lactide copolymer connected by urethane linkages, and the fibrinogen-based sealant comprises fibrinogen, thrombin, and CaCl2. In contrast to similar patches known in the art, the polymer backing serves to seal the tissue to which the patch is applied, and the sealant acts only to bind the patch to the affected tissue. The patch does not include any mesh, woven, or non-woven component. Methods of production and use of the patch are also disclosed.
-
公开(公告)号:US11045532B2
公开(公告)日:2021-06-29
申请号:US16161671
申请日:2018-10-16
申请人: EpiVax, Inc.
发明人: Anne De Groot , William Martin , Daniel S. Rivera
摘要: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
-
公开(公告)号:US11015204B2
公开(公告)日:2021-05-25
申请号:US15994683
申请日:2018-05-31
发明人: Pattraranee Limphong , Carlos G. Perez-Garcia , Kiyoshi Tachikawa , Padmanabh Chivukula , Arisa Cale , Angel I-Jou Leu , Jared Davis
IPC分类号: C12N15/52 , C12N15/82 , C07K14/805 , C07K14/775 , C07K14/75 , C07K14/47 , C07K14/415 , C07K14/505 , A61K38/01 , A61K38/17 , A61K38/42 , A61K38/36 , A61K38/18
摘要: This invention provides expressible polynucleotides, which can express a target protein or polypeptide. Synthetic mRNA constructs for producing a protein or polypeptide can contain one or more 5′ UTRs, where a 5′ UTR may be expressed by a gene of a plant. In some embodiments, a 5′ UTR may be expressed by a gene of a member of Arabidopsis genus. The synthetic mRNA constructs can be used as pharmaceutical agents for expressing a target protein or polypeptide in vivo.
-
公开(公告)号:US20210115400A1
公开(公告)日:2021-04-22
申请号:US17074074
申请日:2020-10-19
摘要: This present disclosure relates to a bioengineering approach based on microphysiological culture to mimic tissue-tissue interface. Accordingly, the present disclosure provides methods, compositions and kits related to the approach.
-
公开(公告)号:US10925941B2
公开(公告)日:2021-02-23
申请号:US16161674
申请日:2018-10-16
申请人: EpiVax, Inc.
发明人: Anne De Groot , William Martin , Daniel S. Rivera
摘要: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
-
公开(公告)号:US10751397B2
公开(公告)日:2020-08-25
申请号:US16015784
申请日:2018-06-22
申请人: EpiVax, Inc.
发明人: Anne De Groot , William Martin , Daniel S. Rivera
摘要: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
-
公开(公告)号:US10577403B2
公开(公告)日:2020-03-03
申请号:US16438735
申请日:2019-06-12
申请人: ModernaTX, Inc.
IPC分类号: A61K48/00 , A61K38/17 , A61K47/54 , A61K9/127 , C07K14/535 , A61K31/7088 , A61K38/48 , C07K14/745 , C07K16/28 , C07K16/32 , C12N9/02 , C12N9/64 , A61K38/19 , A61K38/21 , A61K38/36 , A61K38/44 , A61K39/395 , C07K14/475 , C07K14/505 , C07K14/525 , C07K14/56 , C07K14/565 , C07K14/75 , A61K47/10 , A61K38/18 , A61K9/14 , C07K14/47 , C12N15/85 , A61K9/50 , C12N15/88 , C07K19/00 , A61K31/7115 , C07K14/005 , C12N15/11 , C12N9/00 , A61K9/00
摘要: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.
-
-
-
-
-
-
-
-
-